Curreri A., Sankholkar D., Mitragotri S., Zhao Z. 2022. RNA therapeutics in the clinic. Bioeng. Transl. Med. e10374.
Halloy F., Biscans A., Bujold K.E., Debacker A., Hill A.C., Lacroix A., Luige O., Strömberg R., Sundstrom L., Vogel J., Ghidini A. 2021. Innovative developments and emerging technologies in RNA therapeutics. RNA Biol. 19, 313–332.
Zhou L.Y., Qin Z., Zhu Y.H., He Z.Y., Xu T. 2019. Current RNA-based therapeutics in clinical trials. Curr. Gene Ther. 19, 172–196.
Quemener A.M., Centomo M.L., Sax S.L., Panella R. 2022. Small drugs, huge impact: the extraordinary impact of antisense oligonucleotides in research and drug development. Molecules. 27, 536.
Article CAS PubMed PubMed Central Google Scholar
Crooke S.T., Liang X.H., Baker B.F., Crooke R.M. 2021. Antisense technology: a review. J. Biol. Chem. 296, 100416.
Article CAS PubMed PubMed Central Google Scholar
Crooke S.T., Baker B.F., Crooke R.M., Liang X.H. 2021. Antisense technology: an overview and prospectus. Nat. Rev. Drug Discov. 20, 427–453.
Article CAS PubMed Google Scholar
Arzumanov A., Walsh A.P., Rajwanshi V.K., Kumar R., Wengel J., Gait M.J. 2001. Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides. Biochemistry. 40, 14645–14654.
Article CAS PubMed Google Scholar
Arechavala-Gomeza V., Khoo B., Aartsma-Rus A. 2014. Splicing modulation therapy in the treatment of genetic diseases. Appl. Clin. Genet. 7, 245–252.
PubMed PubMed Central Google Scholar
Crooke S.T. 2017. Molecular mechanisms of antisense oligonucleotides. Nucleic Acid Ther. 27, 70–77.
Article CAS PubMed PubMed Central Google Scholar
Eckstein F. 2014. Phosphorothioates, essential components of therapeutic oligonucleotides. Nucleic Acid Ther. 24, 374–387.
Article CAS PubMed Google Scholar
Shen W., De Hoyos C.L., Migawa M.T., Vickers T.A., Sun H., Low A., Bell T.A. 3rd, Rahdar M., Mukhopadhyay S., Hart C.E., Bell M., Riney S., Murray S.F., Greenlee S., Crooke R.M., Liang X.H., Seth P.P., Crooke S.T. 2019. Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index. Nat. Biotechnol. 37, 640–650.
Article CAS PubMed Google Scholar
Crooke S.T., Vickers TA., Liang X.H. 2020. Phosphorothioate modified oligonucleotide-protein interactions. Nucleic Acids Res. 48, 5235–5253.
Article PubMed PubMed Central Google Scholar
Shen W., De Hoyos C.L., Sun H., Vickers T.A., Liang X.H., Crooke S.T. 2018. Acute hepatotoxicity of 2' fluoro-modified 5-10-5 gapmer phosphorothioate oligonucleotides in mice correlates with intracellular protein binding and the loss of DBHS proteins. Nucleic Acids Res. 46, 2204–2217.
Article CAS PubMed PubMed Central Google Scholar
Chelobanov B.P., Burakova E.A., Prokhorova D.V., Fokina A.A., Stetsenko D.A. 2017. New oligodeoxynucleotide derivatives containing N-(methanesulfonyl)-phosphoramidate (mesyl phosphoramidate) internucleotide group. Russ. J. Bioorg. Chem. 43, 664–668.
Miroshnichenko S.K., Patutina O.A., Burakova E.A., Chelobanov B.P., Fokina A.A., Vlassov V.V., Altman S., Zenkova M.A., Stetsenko D.A. 2019. Mesyl phosphoramidate antisense oligonucleotides as an alternative to phosphorothioates: improved biochemical and biological properties. Proc. Natl. Acad. Sci. U. S. A. 116, 1229–1234.
Article CAS PubMed PubMed Central Google Scholar
Liang X.H., Shen W., Sun H., Kinberger G.A., Prakash T.P., Nichols J.G., Crooke S.T. 2016. Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2'-modifications and enhances antisense activity. Nucleic Acids Res. 44, 3892–3907.
Article CAS PubMed PubMed Central Google Scholar
Laurent Q., Martinent R., Moreau D., Winssinger N., Sakai N., Matile S. 2021. Oligonucleotide phosphorothioates enter cells by thiol-mediated uptake. Angew. Chem. Int. Ed. Engl. 60, 19102–19106.
Article CAS PubMed PubMed Central Google Scholar
Meng M., Ducho C. 2018. Oligonucleotide analogues with cationic backbone linkages. Beilstein J. Org. Chem. 14, 1293–1308.
Article CAS PubMed PubMed Central Google Scholar
Danielsen M.B., Wengel J. 2021. Cationic oligonucleotide derivatives and conjugates: a favorable approach for enhanced DNA and RNA targeting oligonucleotides. Beilstein J. Org. Chem. 17, 1828–1848.
Article CAS PubMed PubMed Central Google Scholar
Yanachkov I., Zavizion B., Metelev V., Stevens L.J., Tabatadze Y., Yanachkova M., Wright G., Krichevsky A.M., Tabatadze D.R. 2017. Self-neutralizing oligonucleotides with enhanced cellular uptake. Org. Biomol. Chem. 15, 1363–1380.
Article CAS PubMed PubMed Central Google Scholar
Meng M., Schmidtgall B., Ducho C. 2018. Enhanced stability of DNA oligonucleotides with partially zwitterionic backbone structures in biological media. Molecules. 23, 2941.
Article PubMed PubMed Central Google Scholar
Schmidtgall B., Kuepper A., Meng M., Grossmann T.N., Ducho C. 2018. Oligonucleotides with cationic backbone and their hybridization with DNA: interplay of base pairing and electrostatic attraction. Chem. Eur. J. 24, 1544–1553.
Article CAS PubMed Google Scholar
Prokhorova D.V., Chelobanov B.P., Burakova E.A., Fokina A.A., Stetsenko D.A. 2017. New oligodeoxyribonucleotide derivatives bearing internucleotide N-tosyl phosphoramidate groups: synthesis and complementary binding to DNA and RNA. Russ. J. Bioorg. Chem. 43, 38–42.
Freier S.M., Altmann K.H. 1997. The ups and downs of nucleic acid duplex stability: structure-stability studies on chemically-modified DNA:RNA duplexes. Nucleic Acids Res. 25, 4429–4443.
Article CAS PubMed PubMed Central Google Scholar
Su Y., Fujii H., Burakova E.A., Chelobanov B.P., Fuji-i M., Stetsenko D.A., Filichev V.V. 2019. Neutral and negatively charged phosphate modifications altering thermal stability, kinetics of formation and monovalent ion dependence of DNA G-quadruplexes. Chem. Asian J. 14, 1212–1220.
Article CAS PubMed Google Scholar
Su Y., Edwards P.J.B., Stetsenko D.A., Filichev V.V. 2020. The importance of phosphates for DNA G-quadruplex formation: evaluation of zwitterionic G-rich oligodeoxynucleotides. ChemBioChem. 21, 2455–2466.
Article CAS PubMed Google Scholar
Su Y., Bayarjargal M., Hale T.K., Filichev V.V. 2021. DNA with zwitterionic and negatively charged phosphate modifications: formation of DNA triplexes, duplexes and cell uptake studies. Beilstein J. Org. Chem. 17, 749–761.
Article CAS PubMed PubMed Central Google Scholar
Su Y., Raguraman P., Veedu R.N., Filichev V.V. 2022. Phosphorothioate modification improves exon-skipping of antisense oligonucleotides based on sulfonyl phosphoramidates in mdx mouse myotubes. Org. Biomol. Chem. 20, 3790–3797.
Article CAS PubMed Google Scholar
Beaucage S.L., Caruthers M.H. 1981. Deoxynucleoside phosphoramidites—a new class of key intermediates for deoxypolynucleotide synthesis. Tetrahedron Lett. 22, 1859–1862.
Stec W.J., Zon G., Egan W., Stec B. 1984. Automated solid-phase synthesis, separation, and stereochemistry of phosphorothioate analogs of oligodeoxyribonucleotides. J. Am. Chem. Soc. 106, 6077–6079.
Kupryushkin M.S., Apukhtina V.S., Vasil’eva S.V., Pyshnyi D.V., Stetsenko D.A. 2015. A new simple and convenient method for the preparation of oligonucleotides containing pyrene or cholesterol residues. Izv. Akad. Nauk, Ser. Khim. 64, 1678–1681.
Levina A.S., Repkova M.N., Chelobanov B.P., Bessudnova E.V., Mazurkova M.A., Stetsenko D.A., Zarytova V.F. 2017. Impact of delivery method on antiviral activity of phosphodiester, phosphorothioate, and phosphoryl guanidine oligonucleotides in MDCK cells infected with H5N1 bird flu virus. Mol. Biol. (Moscow). 51, 633–638.
Lomzov A.A., Kupryushkin M.S., Shernyukov A.V., Nekrasov M.D., Dovydenko I.S., Stetsenko D.A., Pyshnyi D.V. 2019. Diastereomers of a mono-substituted phosphoryl guanidine trideoxyribonucleotide: isolation and properties. Biochem. Biophys. Res. Commun. 513, 807–811.
Article CAS PubMed Google Scholar
Burakova E.A., Derzhalova A.Sh., Chelobanov B.P., Fokina A.A., Stetsenko D.A. 2019. New oligodeoxynucleotide derivatives containing N-(sulfonyl)-phosphoramide groups. Russ. J. Bioorg. Chem. 45, 662–668.
Derzhalova A., Markov O., Fokina A., Shiohama Y., Zatsepin T., Fujii M., Zenkova M., Stetsenko D. 2021. Novel lipid-oligonucleotide conjugates containing long-chain sulfonyl phosphoramidate groups: synthesis and biological properties. Appl. Sci. 11, 1174.
Heindl D. Polynucleotide containing a phosphate mimetic. Canadian Patent 2627208, 2006.
Heindl D., Kessler D., Schube A., Thuer W., Giraut A. 2008. Easy method for the synthesis of labeled oligonucleotides. Nucleic Acids Symp. Ser. 52, 405–406.
留言 (0)